Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2011-1-21
pubmed:abstractText
To provide information on the efficacy and safety of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler 230/42mcg (FSC MDI) and its comparable dose of Fluticasone Propionate/Salmeterol DISKUS 250/50mcg (FSC DISKUS) in patients with COPD.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-11316640, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-11866001, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-12877450, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-12970006, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-14533658, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-15219010, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-15641629, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-15654001, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-16490581, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-16963658, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-17314337, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-18291048, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-18614347, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253451-18823257
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:issn
1874-3064
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
86-91
pubmed:dateRevised
2011-7-20
pubmed:year
2010
pubmed:articleTitle
Safety and efficacy of fluticasone propionate/salmeterol hydrofluoroalkane 134a metered-dose-inhaler compared with fluticasone propionate/salmeterol diskus in patients with chronic obstructive pulmonary disease.
pubmed:affiliation
Greenville Pharmaceutical Research, Greenville, SC 864-770-0890, USA.
pubmed:publicationType
Journal Article